Concord Biotech Shareholder Pares Stake For Rs 482 Crore

Ontario Inc. owned 5.39% in the Jhunjhunwala family-backed company as of March 2024.

(Source: Unsplash)

Ontario Inc., a public shareholder of Concord Biotech Ltd., sold a 3.39% stake in the company through the open market for Rs 482 crore on Tuesday. The shareholder offloaded 35.48 lakh shares, representing a 3.39% stake, at Rs 1,361.26 apiece, according to bulk deal data on the NSE.

1575773 Ontario Inc. owned 5.39% of the Jhunjhunwala family-backed company as of March 2024.

Norges Bank, on account of the Government Pension Fund Global, has bought 6 lakh shares in the company, representing 0.57% ownership at Rs 1,386.95 apiece.

Shares of Concord Biotech closed 3.12% lower on Tuesday at Rs 1,395 per share, as compared with a 0.19% decline in the Nifty 50.

The stock had fallen to an over-two-month low during the day, touching Rs 1,355 per share. It has risen 46.44% in 12 months but declined 5.99% year-to-date.

Also Read: RBI's Buyback Operation: Why It Missed The Mark On Liquidity Relief

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
WRITTEN BY
Pratiksha Thayil
Pratiksha covers markets and business news at NDTV Profit. She has a keen i... more
GET REGULAR UPDATES